Figdor: #ampeurope2018 Points out in 1970 Morton described marked tumor regression, with BCG injection w/melanoma (https://t.co/zbnvcUg4yG)
2:10am May 2nd 2018 via Twitter Web Client
Figdor: #ampeurope2018 Illust the complexity of the innate and adaptive immune system: an ensemble, interactions, different in each pt
2:07am May 2nd 2018 via Twitter Web Client
Figdor: #ampeurope2018 Major difficulty: only a fx of pts respond. How will we predict who will respond - the challenge for the next decade
2:06am May 2nd 2018 via Twitter Web Client
Figdor: #ampeurope2018 Shows a K-M curve from people with lymphopenia: less immune cells, do worse '13 https://t.co/EcQH5g6Dcj
2:05am May 2nd 2018 via Twitter Web Client
Figdor: #ampeurope2018 As a novel treatment modality: Immune surveillance in '11 Science https://t.co/HsJtiD3qXR
2:04am May 2nd 2018 via Twitter Web Client
Carl Figdor (Nijmegen NE): #ampeurope2018 Immunotherapies in cancer, 21st century vaccines
2:03am May 2nd 2018 via Twitter Web Client
Q: Classification w/different IDH1 mut type? Nikiforova: #ampeurope2018 The complexity of interpretation; why each… https://t.co/H6Na068boD
12:10pm May 1st 2018 via Twitter Web Client
Q (Andrea F) 59 samples is a 'big number' can you have 2-3 in same sample? Nikiforova: #ampeurope2018 Can include a… https://t.co/e3DmBexaOC
12:05pm May 1st 2018 via Twitter Web Client
Nikiforova: #ampeurope2018 Credits @AMPath staff @Robyn_Temple and Mrudulla for all their hard work!
12:04pm May 1st 2018 via Twitter Web Client
Nikiforova: #ampeurope2018 '15 NEJM https://t.co/tFZsqYQ0gy
12:00pm May 1st 2018 via Twitter Web Client
Nikiforova: #ampeurope2018 WHO Grade I/II/III det by IDH1/2, then TP53 mut/loss and ATRX, then RB1. Shows K-M and difference in outcomes
11:59am May 1st 2018 via Twitter Web Client
Nikiforova: #ampeurope2018 Categorization of brain tumors - she calls GliaSeq. Shows complex example, with RB1 copy… https://t.co/6CNdcKETxE
11:56am May 1st 2018 via Twitter Web Client
Nikiforova: #ampeurope2018 Reviews Tiers 1 through 4 (strong clin sig through benign). (Note: See pg 2 of this Mary… https://t.co/GaI9WdC7ti
11:54am May 1st 2018 via Twitter Web Client
Nikiforova: #ampeurope2018 For reporting: https://t.co/G22oEoj6GC Ex: 45yo F thyroid nodule, TERT and NRAS vars. Se… https://t.co/3dpJKpgFNU
11:47am May 1st 2018 via Twitter Web Client
Nikiforova: #ampeurope2018 shows busy slide, for their v3 ThyroSeq https://t.co/iUqjo0wb2d Prospective double-blin… https://t.co/qztxq82OLQ
11:45am May 1st 2018 via Twitter Web Client
Nikiforova: #ampeurope2018 Not only reporting vars but explanation to physician what it means.
11:41am May 1st 2018 via Twitter Web Client
Nikiforova: #ampeurope2018 Also gene exp, SNVs, indels. 112 genes, 12K hotspots, 120 gene fusion types, preoperative test.
Nikiforova: #ampeurope2018 Give example of Thyroid nodules, after FNA to eliminate 'interdeminate' after pathology.… https://t.co/WKZQe2SMrO
11:40am May 1st 2018 via Twitter Web Client
Nikiforova: #ampeurope2018 PPA is % of known vars detected by NGS cp to orthogonal method. Worksheet: https://t.co/Ph28MLN7Ln
Nikiforova: #ampeurope2018 59 samples per mutation type: shown to reach statistical power. Est PPA and PPV - b/c we… https://t.co/g8a9levdy7
11:35am May 1st 2018 via Twitter Web Client
Nikiforova: #ampeurope2018 And with each type of mutation (SNV, Indels, CNV, SVs), and samples with most common mut… https://t.co/SCV0HNyLDY
11:34am May 1st 2018 via Twitter Web Client
Nikiforova: #ampeurope2018 Est min read depth of >250 reads/amplicon or target for 5% MAF. Validation: using exact sample type.
11:33am May 1st 2018 via Twitter Web Client
Nikiforova: #ampeurope2018 Labs were all over, Larry Jennings proposed statistics (in paper), established distribution of TP, FP
11:32am May 1st 2018 via Twitter Web Client
Nikiforova: #ampeurope2018 Need to understand how the platform works, ref materials and standardizing methods. Depth for LoD determined.
11:31am May 1st 2018 via Twitter Web Client
Nikiforova: #ampeurope2018 Choice of platform, optimization & familiarization phase. All perform well, advantages.… https://t.co/2NBWCeU
11:30am May 1st 2018 via Twitter Web Client
Nikiforova: #ampeurope2018 2 methods: amplification or hybrid capture. Can design a commercial panel, or design. Na… https://t.co/UHW8CMbHCY
11:29am May 1st 2018 via Twitter Web Client
Nikiforova: #ampeurope2018 Validation, it's long, will make highlights and observations. Majority of clin labs: targeted over WGS, WES, RNA
11:27am May 1st 2018 via Twitter Web Client
Nikiforova: #ampeurope2018 And a long process, 14-18 months. JMD Validation: https://t.co/siZw2tdgJn Reporting: https://t.co/G22oEoj6GC
11:25am May 1st 2018 via Twitter Web Client
Nikiforova: #ampeurope2018 2012: the clinical NGS era began. At that time, no guidelines existed. In '14: initiated… https://t.co/IqA9exyXEL
11:24am May 1st 2018 via Twitter Web Client
Marina Nikiforova (Univ Pittsburgh, USA): #ampeurope2018 Practice Guidelines for Validation, Interpretation and Rep… https://t.co/o0bw7QNtvu
11:22am May 1st 2018 via Twitter Web Client
Q: Any look at ncRNA at the sc level? Pugh: #ampeurope2018 A current 'huge blind spot'. Bulk is never polyA; for sc… https://t.co/TRoKXCDQ64
11:10am May 1st 2018 via Twitter Web Client
Q: Can CITE-seq be only surface proteins? Pugh: #ampeurope2018 Currently, yes only surface to-date.
11:04am May 1st 2018 via Twitter Web Client
Pugh: #ampeurope2018 Concl with the Human Cell Atlas, the Chan Zuckerberg intitiative. https://t.co/Ts13bnB0gh
11:00am May 1st 2018 via Twitter Web Client
Pugh: #ampeurope2018 Upcoming methods - DroNc-Seq '17 Nature Methods https://t.co/x8EJboai7I And CITE-Seq https://t.co/LOmMoxTtHD
Pugh: #ampeurope2018 Combining cancer, healthy cell data highlights shared and private cellular populations.
10:52am May 1st 2018 via Twitter Web Client
Pugh: #ampeurope2018 Sees tumor cells, BTSC line, TIL immune cells. Treated each chr as a pathway. Inferred Chr 7, Chr 10 gain/loss
10:47am May 1st 2018 via Twitter Web Client
Pugh: #ampeurope2018 Large, freq loss of chr6 at scWGS, unexplained. Secret sauce is dissociation of brain tumor tissue. Shows tSNE1/2 plots
10:46am May 1st 2018 via Twitter Web Client
Pugh: #ampeurope2018 Glioblastomas have self-renewing cancer stem cells. Shows scRNA core set of genes, then tracked to chr6.
10:44am May 1st 2018 via Twitter Web Client
Pugh: #ampeurope2018 In cancer: scRNA to understand early, monitor, and see mech of resp/resistance. Stand Up to C… https://t.co/o3izjXltRg
10:40am May 1st 2018 via Twitter Web Client
Pugh: #ampeurope2018 Gene sets, pathways. '17 https://t.co/LOmMoxTtHD But a lack of a reference standard set.
Pugh: #ampeurope2018 Review of challenges in scRNA analysis '15 Nat Rev Genetics https://t.co/x1z5y9TBad Many ways to readout PCA.
10:37am May 1st 2018 via Twitter Web Client
Pugh: #ampeurope2018 Full length can also find coding mutaitons. Baran-Gale ref compares methods. Shows fig: 3 exons vs end-reads.
10:35am May 1st 2018 via Twitter Web Client
Pugh: #ampeurope2018 Difference: transcript structure throughout mRNA in SmartSeq 2, only 10's of thousands. 10X does only end-reads.
10:34am May 1st 2018 via Twitter Web Client
Pugh: #ampeurope2018 SmartSeq2 https://t.co/sjwypWsLB2 Cheap. $2-4/cell https://t.co/lYl7UQTxWl
10:33am May 1st 2018 via Twitter Web Client
Pugh: #ampeurope2018 Rev on sc techniques in immunol https://t.co/STQmZGLeAE Talk only about 10X Genomics, SmartSeq2
10:32am May 1st 2018 via Twitter Web Client
Pugh: #ampeurope2018 Immune infiltrate - but very different expression profiles on a single-cell level. Multiple pa… https://t.co/K8CE3k4S5J
10:28am May 1st 2018 via Twitter Web Client
Pugh: #ampeurope2018 Estimates of immune and stromal cell content, scored from bulk GEx data. Yoshihara et al '13 https://t.co/aV6EsrlwUx
10:26am May 1st 2018 via Twitter Web Client
Pugh: #ampeurope2018 '13 fig https://t.co/X3qRbM2NYM worked on infrastructure w/fresh biopsies with INSPIRE program, Pembro resp
10:25am May 1st 2018 via Twitter Web Client
Pugh: #ampeurope2018 Directs a research core for single-cell seq; a bowls of M&Ms, different colors, innards. Tumor… https://t.co/gfReNQ
10:24am May 1st 2018 via Twitter Web Client
Trevor Pugh (Princess Margaret, Toronto) #ampeurope2018 Simultaneous Analysis of Cancer Clones and Immune Microenv… https://t.co/NolmExAOje
10:22am May 1st 2018 via Twitter Web Client